期刊文献+

左氧氟沙星片剂绝对生物利用度研究 被引量:20

Absolute bioavailability of levofloxacin tablet in healthy Chinese male subjects
下载PDF
导出
摘要 目的在中国健康志愿者中进行左氧氟沙星(可乐必妥)500mg片剂药代动力学研究,并以左氧氟沙星500mg(100ml)注射液为对照,研究口服片剂的绝对生物利用度。方法10名受试者分别单剂空腹口服左氧氟沙星500mg片剂和单次静脉滴注500mg(100ml)注射液。以高效液相色谱(HPLC)-荧光法测定血、尿样中左氧氟沙星药物浓度。结果受试者单剂空腹口服左氧氟沙星500mg片剂后平均Cmax实测值为(6.20±2.51)mg/L,Tmax为(0.91±0.54)h,t1/2为(6.71±0.88)h,AUC0-∞为(41.88±5.72)mg·h/L,24h内尿中平均累积排出率为(69.40±7.27)%,其与注射液相比绝对生物利用度几何均数比为107.5%(以AUC0-∞计),90%可信区间为(97.72~118.25)%。结论左氧氟沙星500mg片剂单次口服给药后吸收迅速,且吸收完全。提示临床可以每日一次,500mg顿服,用于左氧氟沙星先静脉给药,继以口服的序贯疗法。 Objective To investigate the pharmacokinetics and absolute bioavailability of levofloxacin tablet in healthy Chinese subjects in order to provide rationale for developing safe and effective clinical dosage regimen in Chinese patients. Methods Ten subjects took single oral dose and intravenous of 500mg(100ml) levofloxacin, respectively. The concentrations of levofloxacin in plasma and urine were determined by high performance liquid chromatogram-fluorescence method. Results The pharmacokinetic parameters following single oral dose of 500mg levofloxacin tablet were as follows. The mean of Cmax was (6.20±2.51) mg/L. The mean of Tmax was (0.91±0.54) h. The mean oft1/2 was (6.71±0.88) h. The mean ofAUC0-∞ was (41.88±5.72) mgoh/L. The mean of accumulative urinary excretion with 24 hours post dosing was (69.40±7.27) %. The absolute bioavailability was (108.20±12.68) %. Conclusion The results indicate that levofloxacin was absorbed fast and completely. The preparations of tablet and intravenous of levofloxacin were equivalent.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第1期49-53,共5页 Chinese Journal of Antibiotics
关键词 左氧氟沙星 高效液相色谱 药代动力学 Levofloxacin High performance liquid chromatogram Pharmacokinetics
  • 相关文献

参考文献7

  • 1Chien S C, Rogge M C, Gisclon L G, et al. Pharmacokinetic Profile of Levofloxacin following Once-Daily 500-Milligram Oral or Intravenous Doses[J]. Antimicrob Agents Chemother,1997, 41(10): 2256 - 2260.
  • 2Chow A T, Fowler C,Williams R R, et al.Safety and Pharmacokinetics of Multiple 750-Milligram doses of Intravenous Levofloxacin in Healthy Volunteers[J]. Antimicrob Agents Chemother, 2001, 45(7): 2122 - 2125.
  • 3Zhang L, Li J T, Lu Y, et al. Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects[J]. Acta Pharmacol Sin, 2002, 23(4): 381 - 384.
  • 4Drusano G L, Preston S L, Van Guilder M, et al. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin[J]. Antimicrob Agents Chemother, 2000, 144(8): 2046 - 2051.
  • 5Villani P, Viale P, Signorini L, et al. Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy[J]. Antimicrob Agents Chemother, 2001, 45(7): 2160 - 2162.
  • 6Drusano G L, Preston S L, Gotfried M H, et al. Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation[J]. Antimicrob Agents Chemother, 2002, 46(2) 586 - 589.
  • 7张莉,李家泰,吕媛,李曼宁,张永龙,刘燕,李天云,张建伟.左氧氟沙星注射液及口服片剂在健康人体内的药动学研究[J].中国药学杂志,2001,36(12):834-837. 被引量:31

二级参考文献3

共引文献30

同被引文献172

引证文献20

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部